APPLY NOW

    Current Studies

    Our portfolio includes a variety of marketed drugs such as Opzelura, Skyrizi, Otezla, Tremfya,as well as novel investigational drugs in various forms including topicals, oral medications, injectables, and IV therapies. We have conducted phase 1 through 4 trials for conditions such as psoriasis, eczema, hidradenitis suppurativa, vitiligo, lichen planus, alopecia, and more!
    Alopecia Areata

    Status: RECRUITING

    • Adult Participants with hair loss affecting >50% of the scalp
    • Amlitelimab monotherapy by subcutaneous injection (placebo-controlled)

    If you are interested in participating, please click the gold ‘PARTCIPATE NOW’ button above.
    You may also email research@apexskin.com or call us at 440-940-2739

    Atopic Dermatitis (eczema)

    Status: RECRUITING

    • Adult participants with moderate-to-severe atopic dermatitis (eczema)
    • Subcutaneous injection (placebo-controlled)

    If you are interested in participating, please click the gold ‘PARTCIPATE NOW’ button above.
    You may also email research@apexskin.com or call us at 440-940-2739

    Gorlin Syndrome

    Status: RECRUITING in Canton and Mayfield Heights

    • A study of Patidegib Gel 2% for the reduction of disease burden of persistently developing basal cell carcinomas in subjects with Gorlin Syndrome (placebo-controlled)

    If you are interested in participating, please click the gold ‘PARTCIPATE NOW’ button above.
    You may also email research@apexskin.com or call us at 440-940-2739

    Pyoderma Gangrenosum

    Status: RECRUITING

    • IV Infusion of Vilobelimab for Ulcerative Pyoderma Gangrenosum (placebo-controlled)

    If you are interested in participating, please click the gold ‘PARTCIPATE NOW’ button above.
    You may also email research@apexskin.com or call us at 440-940-2739

    Hidradenitis Suppurativa

    Status: RECRUITING

    • Subcutaneous injection for adult patients with moderate to severe hidradenitis suppurativa
    • Placebo controlled for the first 16-weeks of treatment
    • Possibility of receiving open label treatment for an additional 3-years

    If you are interested in participating, please click the gold ‘PARTCIPATE NOW’ button above.
    You may also email research@apexskin.com or call us at 440-940-2739

    Plaque Psoriasis

    Status: RECRUITING

    • Oral treatment for patients with moderate-to-severe Plaque Psoriasis (placebo-controlled)

    If you are interested in participating, please click the gold ‘PARTCIPATE NOW’ button above.
    You may also email research@apexskin.com or call us at 440-940-2739

    Chronic Urticaria

    Status: RECRUITING

    • Chronic Spontaneous Urticaria
    • Subcutaneous injection of Barzolvolimab (placebo-controlled)

    If you are interested in participating, please click the gold ‘PARTCIPATE NOW’ button above.
    You may also email research@apexskin.com or call us at 440-940-2739